1. Home
  2. COEP vs BODI Comparison

COEP vs BODI Comparison

Compare COEP & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • BODI
  • Stock Information
  • Founded
  • COEP 2017
  • BODI 1998
  • Country
  • COEP United States
  • BODI United States
  • Employees
  • COEP N/A
  • BODI N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • BODI Industrial Machinery/Components
  • Sector
  • COEP Health Care
  • BODI Industrials
  • Exchange
  • COEP Nasdaq
  • BODI Nasdaq
  • Market Cap
  • COEP 27.4M
  • BODI 25.4M
  • IPO Year
  • COEP N/A
  • BODI N/A
  • Fundamental
  • Price
  • COEP $10.72
  • BODI $3.91
  • Analyst Decision
  • COEP
  • BODI Buy
  • Analyst Count
  • COEP 0
  • BODI 2
  • Target Price
  • COEP N/A
  • BODI $10.00
  • AVG Volume (30 Days)
  • COEP 59.5K
  • BODI 13.1K
  • Earning Date
  • COEP 08-15-2025
  • BODI 08-05-2025
  • Dividend Yield
  • COEP N/A
  • BODI N/A
  • EPS Growth
  • COEP N/A
  • BODI N/A
  • EPS
  • COEP N/A
  • BODI N/A
  • Revenue
  • COEP $62,874.00
  • BODI $371,113,000.00
  • Revenue This Year
  • COEP N/A
  • BODI N/A
  • Revenue Next Year
  • COEP N/A
  • BODI N/A
  • P/E Ratio
  • COEP N/A
  • BODI N/A
  • Revenue Growth
  • COEP N/A
  • BODI N/A
  • 52 Week Low
  • COEP $2.31
  • BODI $3.38
  • 52 Week High
  • COEP $13.70
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • COEP 55.11
  • BODI 42.07
  • Support Level
  • COEP $11.30
  • BODI $4.30
  • Resistance Level
  • COEP $11.46
  • BODI $4.79
  • Average True Range (ATR)
  • COEP 0.95
  • BODI 0.32
  • MACD
  • COEP -0.05
  • BODI -0.01
  • Stochastic Oscillator
  • COEP 38.82
  • BODI 8.93

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: